本页面由Tiger Trade Technology Pte. Ltd.提供服务

Xenetic Biosciences Inc

2.24
+0.09004.19%
盘后2.260.0200+0.89%16:26 EST
成交量:3.45万
成交额:7.65万
市值:513.20万
市盈率:-1.09
高:2.29
开:2.20
低:2.15
收:2.15
52周最高:13.93
52周最低:1.90
股本:229.11万
流通股本:191.78万
量比:0.71
换手率:1.80%
股息:- -
股息率:- -
每股收益(TTM):-2.0467
每股收益(LYR):-2.5694
净资产收益率:-57.43%
总资产收益率:-31.56%
市净率:1.30
市盈率(LYR):-0.87

数据加载中...

2024/08/14

重要事件披露

Form 8-K - Current report
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/18

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/06/21

重要事件披露

Form 8-K - Current report
2024/05/22

重要事件披露

Form 8-K - Current report
2024/05/10

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/26

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/22

重要事件披露

Form 8-K - Current report
2024/03/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/12

重要事件披露

Form 8-K - Current report
2023/12/09

重要事件披露

Form 8-K - Current report
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/11

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/15

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/06/06

重要事件披露

Form 8-K - Current report